Ocular surface disease can be a big problem for glaucoma patients – even to the point where they may stop taking their glaucoma medication (see part 1 of this article). Is there a solution to this problem? Leading ophthalmologist Mr Shabbir Mohamed talks treatments and the future.
Glaucoma is all too common, affecting around 480,000 people in England alone. This condition involves excessive pressure on the optic nerve, leading to loss of vision. To make matters worse, patients may also have ocular surface disease, which can hamper glaucoma treatment and further affect the patient’s life. Expert ophthalmologist Mr Shabbir Mohamed explains.